Table 3.
Blood biochemistry of the control and treatment groups of obese subjects.
| Parameters | Groups | Probability values∗ | |
|---|---|---|---|
| Control (n = 10) | Treatment (n = 21) | ||
| Complete blood count (g/dL) | |||
| Hemoglobin | 12.44 ± 0.94 | 12.38 ± 0.84 | 0.96 |
| Eosinophils | 0.14 ± 0.024 | 0.14 ± 0.024 | 1 |
| ESR | 17.80 ± 0.80 | 16.60 ± 0.67 | 0.28 |
| Lymphocytes | 36.60 ± 0.40b | 39.20 ± 0.91a | 0.03 |
| Monocytes | 0.24 ± 0.024 | 0.24 ± 0.024 | 1 |
| Polymorphs | 60 ± 0.04 | 54.60 ± 2.46 | 0.59 |
| TLC | 7720 ± 185.47 | 7660.0 ± 60.0 | 0.76 |
| Lipid profile (mg/dL) | |||
| Triglycerides | 146.80 ± 1.73a | 140.30 ± 2.48b | 0.02 |
| Total cholesterol | 188.90 ± 3.06a | 164.10 ± 3.35b | 0.01 |
| HDL | 46.10 ± 1.73b | 50.70 ± 1.35a | 0.05 |
| LDL | 134.90 ± 3.51a | 122.70 ± 2.55b | 0.01 |
| TBARS (μmol) | 6.08 ± 0.07a | 5.66 ± 0.05b | 0.001 |
Data are presented as the means ± SEM of the control and treatment groups. ∗Probability values (P ≤ 0.05) show significant differences between the groups. a,bDifferent letters in rows show a significant difference at P ≤ 0.05. TC: total cholesterol; HDL: high-density lipoprotein; LDL: low-density lipoprotein; Hb: hemoglobin; ESR: erythrocyte sedimentation rate; TLC: total leukocyte count.